Climb Bio Inc (CLYM) — Long-term Investment Intensity
Climb Bio Inc (CLYM) has a Long-term Investment Intensity of 24.1% as of March 2026. Long-term investments of $36.74 Million represent 24.1% of total assets of $152.37 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Climb Bio Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Climb Bio Inc Long-term Investment Intensity (2021–2025)
This chart shows how Climb Bio Inc's Long-term Investment Intensity has evolved across 3 annual periods from 2021 to 2025. As of March 2026, the intensity stands at 24.1%, reflecting long-term investments of $36.74 Million against total assets of $152.37 Million USD. Explore Climb Bio Inc (CLYM) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Climb Bio Inc (2021–2025)
The table below presents the year-by-year Long-term Investment Intensity for Climb Bio Inc from 2021 to 2025, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Climb Bio Inc market cap and net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 35.5% | $59.57 Million | $167.74 Million | ▲ +7.1 pp |
| 2024 | 28.4% | $61.61 Million | $217.19 Million | ▲ +14.0 pp |
| 2021 | 14.4% | $24.92 Million | $173.24 Million | — |